Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pulmonary Hypertension, April 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 101 articles:
HTML format


 

Single Articles

  1. SONAGLIONI A, Baravelli M, Cassandro R, Torre O, et al
    Hemodynamic Mechanisms of Exercise-Induced Pulmonary Hypertension in Patients with Lymphangioleiomyomatosis: The Role of Exercise Stress Echocardiography.
    J Am Soc Echocardiogr. 2018 Mar 28. pii: S0894-7317(18)30096.
    Abstract    

    Abstract available

  2. KARAMPITSAKOS T, Tzouvelekis A, Chrysikos S, Bouros D, et al
    Pulmonary hypertension in patients with interstitial lung disease.
    Pulm Pharmacol Ther. 2018 Mar 29. pii: S1094-5539(17)30242.
    Abstract    

    Abstract available

  3. HAW A, Palevsky HI
    Pulmonary hypertension in chronic hemolytic anemias: Pathophysiology and treatment.
    Respir Med. 2018;137:191-200.
    Abstract    

    Abstract available

  4. MENACHEM JN, Birati EY, Zamani P, Owens AT, et al
    Pulmonary hypertension: Barrier or just a bump in the road in transplanting adults with congenital heart disease.
    Congenit Heart Dis. 2018 Mar 30. doi: 10.1111/chd.12606.
    Abstract    

    Abstract available

  5. HAJI K, Wong CX, Chandra N, Truong H, et al
    Pulmonary Hypertension in Central Australia: A Community-Based Cohort Study.
    Heart Lung Circ. 2018 Mar 6. pii: S1443-9506(18)30083.
    Abstract    

    Abstract available

  6. SCHWARZ EI, Ulrich S
    [Pulmonary hypertension in connective tissue disease].
    Z Rheumatol. 2018 Mar 28. pii: 10.1007/s00393-018-0443.
    Abstract    

    Abstract available

  7. SPAZZAPAN M, Sastry P, Dunning J, Nordsletten D, et al
    The Use of Biophysical Flow Models in the Surgical Management of Patients Affected by Chronic Thromboembolic Pulmonary Hypertension.
    Front Physiol. 2018;9:223.
    Abstract    

    Abstract available

  8. HARDY MEL, Pervolaraki E, Bernus O, White E, et al
    Dynamic Action Potential Restitution Contributes to Mechanical Restitution in Right Ventricular Myocytes From Pulmonary Hypertensive Rats.
    Front Physiol. 2018;9:205.
    Abstract    

    Abstract available

  9. NASSAR SZ, Hassaan PS, Abdelmonsif DA, ElAchy SN, et al
    Cardioprotective effect of cerium oxide nanoparticles in monocrotaline rat model of pulmonary hypertension: A possible implication of endothelin-1.
    Life Sci. 2018 Mar 24. pii: S0024-3205(18)30159.
    Abstract    

    Abstract available

  10. SHANG W, Li Y, Ren Y, Li W, et al
    Prevalence of pulmonary hypertension in patients with chronic kidney disease without dialysis: a meta-analysis.
    Int Urol Nephrol. 2018 Mar 26. pii: 10.1007/s11255-018-1853.
    Abstract    

    Abstract available

  11. GUIMARON S, Guihaire J, Amsallem M, Haddad F, et al
    Current Knowledge and Recent Advances of Right Ventricular Molecular Biology and Metabolism from Congenital Heart Disease to Chronic Pulmonary Hypertension.
    Biomed Res Int. 2018;2018:1981568.
    Abstract    

    Abstract available

  12. AHMADIPOUR B, Sharifi M, Khajali F
    Pulmonary hypertensive response of broiler chickens to arginine and guanidinoacetic acid under high-altitude hypoxia.
    Acta Vet Hung. 2018;66:116-124.
    Abstract    

    Abstract available

  13. NAEIJE R, Faoro V
    The breathlessness of pulmonary hypertension.
    Int J Cardiol. 2018;259:183-184.
    Abstract    



  14. FARINA S, Bruno N, Agalbato C, Contini M, et al
    Physiological insights of exercise hyperventilation in arterial and chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2018;259:178-182.
    Abstract    

    Abstract available

  15. TARTAVOULLE TM, Karpinski AC, Aubin A, Kluger BM, et al
    Multidimensional fatigue in pulmonary hypertension: prevalence, severity and predictors.
    ERJ Open Res. 2018;4.
    Abstract    

    Abstract available

  16. ISHIHARA S, Kioka H, Ohtani T, Asano Y, et al
    EXPRESS: Successful treatment of severe combined post- and pre-capillary pulmonary hypertension in a patient with idiopathic restrictive cardiomyopathy.
    Pulm Circ. 2018 Jan 1:2045894018770131. doi: 10.1177/2045894018770131.
    Abstract    



  17. AMDANI SM, Mian MUM, Thomas RL, Ross RD, et al
    NT-pro BNP-A marker for worsening respiratory status and mortality in infants and young children with pulmonary hypertension.
    Congenit Heart Dis. 2018 Mar 25. doi: 10.1111/chd.12601.
    Abstract    

    Abstract available

  18. TIGGES E, Blankenberg S, von Bardeleben RS, Zurn C, et al
    Implication of pulmonary hypertension in patients undergoing MitraClip therapy: results from the German transcatheter mitral valve interventions (TRAMI) registry.
    Eur J Heart Fail. 2018;20:585-594.
    Abstract    

    Abstract available

  19. KUMARASINGHE G, Jain P, Jabbour A, Lai J, et al
    Comparison of continuous-flow ventricular assist device therapy with intensive medical therapy in fixed pulmonary hypertension secondary to advanced left heart failure.
    ESC Heart Fail. 2018 Mar 24. doi: 10.1002/ehf2.12284.
    Abstract    

    Abstract available

  20. CHENBHANICH J, Leelayuwatanakul N, Phowthongkum P
    Klippel-Trenaunay-Weber syndrome as a cause of chronic thromboembolic pulmonary hypertension.
    BMJ Case Rep. 2018;2018.
    Abstract    



  21. CORDEANU EM, Younes W, Canuet M, Mirea C, et al
    Real life practices of chronic thromboembolic pulmonary hypertension screening. Results from the REMOTEV observational study.
    Clin Respir J. 2018 Mar 23. doi: 10.1111/crj.12794.
    Abstract    



  22. JORGE-RIPPER C, Vega-Ocana P
    An atypical cause of pulmonary hypertension in the elderly.
    Rev Clin Esp. 2018 Mar 19. pii: S0014-2565(18)30058.
    Abstract    



  23. THENAPPAN T, Ormiston ML, Ryan JJ, Archer SL, et al
    Pulmonary arterial hypertension: pathogenesis and clinical management.
    BMJ. 2018;360:j5492.
    Abstract    

    Abstract available

  24. KUANG HY, Wu YH, Yi QJ, Tian J, et al
    The efficiency of endothelin receptor antagonist bosentan for pulmonary arterial hypertension associated with congenital heart disease: A systematic review and meta-analysis.
    Medicine (Baltimore). 2018;97:e0075.
    Abstract    

    Abstract available

  25. HE J, Li X, Luo H, Li T, et al
    Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4.
    J Am Soc Hypertens. 2017 Mar 27. pii: S1933-1711(17)30098.
    Abstract    

    Abstract available

  26. MU YP, Lin DC, Zheng SY, Jiao HX, et al
    Transient Receptor Potential Melastatin-8 Activation Induces Relaxation of Pulmonary Artery by Inhibition of Store-Operated Calcium Entry in Normoxic and Chronic Hypoxic Pulmonary Hypertensive Rats.
    J Pharmacol Exp Ther. 2018 Apr 5. pii: jpet.117.247320.
    Abstract    

    Abstract available

  27. WANG Y, Yan L, Zhang Z, Prado E, et al
    Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension.
    Front Pharmacol. 2018;9:241.
    Abstract    

    Abstract available

  28. TZOUVELEKIS A, Herazo-Maya JD, Ryu C, Chu JH, et al
    S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertension.
    Respirology. 2018 Apr 2. doi: 10.1111/resp.13302.
    Abstract    

    Abstract available

  29. KLOK FA, Delcroix M, Bogaard HJ
    Chronic thromboembolic pulmonary hypertension from the perspective of patients with pulmonary embolism.
    J Thromb Haemost. 2018 Apr 2. doi: 10.1111/jth.14016.
    Abstract    

    Abstract available

  30. KHALID S, Daw H, Jacob M, Nakashima M, et al
    T cell Large Granular Lymphocytic Leukemia with Pulmonary Hypertension.
    Gulf J Oncolog. 2018;1:72-74.
    Abstract    

    Abstract available

  31. MACHIREDDY K, Myint Z, Dein E, Mathai SC, et al
    Mycophenolate Mofetil in a Lupus Patient with Pulmonary Hypertension.
    Cureus. 2018;10:e2121.
    Abstract    

    Abstract available

  32. SATO T, Mori M, Aoki J, Tanabe K, et al
    Pulmonary Tumor Thrombotic Microangiopathy due to Advanced Gastric Cancer with Virchow's Node Metastasis.
    Int Heart J. 2018;59:443-447.
    Abstract    

    Abstract available

  33. DIAZ-GOMEZ JL, Ripoll JG, Mira-Avendano I, Moss JE, et al
    Multidisciplinary Perioperative Management of Pulmonary Arterial Hypertension in Patients Undergoing Noncardiac Surgery.
    South Med J. 2018;111:64-73.
    Abstract    

    Abstract available

  34. YAMAMURA A, Fujitomi E, Ohara N, Tsukamoto K, et al
    Tadalafil induces antiproliferation, apoptosis, and phosphodiesterase type 5 downregulation in idiopathic pulmonary arterial hypertension in vitro.
    Eur J Pharmacol. 2017 Jun 8. pii: S0014-2999(17)30400.
    Abstract    

    Abstract available

  35. BHAT L, Hawkinson J, Cantillon M, Reddy DG, et al
    RP5063, a novel, multimodal, serotonin receptor modulator, prevents monocrotaline-induced pulmonary arterial hypertension in rats.
    Eur J Pharmacol. 2017 May 31. pii: S0014-2999(17)30380.
    Abstract    

    Abstract available

  36. BHAT L, Hawkinson J, Cantillon M, Reddy DG, et al
    RP5063, a novel, multimodal, serotonin receptor modulator, prevents Sugen 5416-hypoxia-induced pulmonary arterial hypertension in rats.
    Eur J Pharmacol. 2017 May 30. pii: S0014-2999(17)30381.
    Abstract    

    Abstract available

  37. SAVALE L, Guignabert C, Weatherald J, Humbert M, et al
    Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era.
    Eur Respir Rev. 2018;27.
    Abstract    

    Abstract available

  38. DU X, Wang Y, Ye Q
    [Genetic analysis of a family affected with pulmonary hypertension secondary to hereditary hemorrhagic telangiectasia].
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2018;35:197-201.
    Abstract    

    Abstract available

  39. RAFIKOVA O, Williams ER, McBride ML, Zemskova M, et al
    Hemolysis-induced Lung Vascular Leakage Contributes to the Development of Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2018 Apr 13. doi: 10.1165/rcmb.2017-0308.
    Abstract    

    Abstract available

  40. SARKAR MS, Desai PM
    Pulmonary hypertension and cardiac anesthesia: Anesthesiologist's perspective.
    Ann Card Anaesth. 2018;21:116-122.
    Abstract    

    Abstract available

  41. LEVY M, Del Cerro MJ, Nadaud S, Vadlamudi K, et al
    Safety, efficacy and Management of subcutaneous treprostinil infusions in the treatment of severe pediatric pulmonary hypertension.
    Int J Cardiol. 2018 Mar 15. pii: S0167-5273(17)35324.
    Abstract    

    Abstract available

  42. BRYCE Y, Santos E
    Balloon pulmonary angioplasty in a patient with prostate cancer and chronic thromboembolic pulmonary hypertension.
    Clin Imaging. 2018;50:185-187.
    Abstract    

    Abstract available

  43. SHIMOKAWAHARA H, Ogawa A, Mizoguchi H, Yagi H, et al
    Vessel Stretching Is a Cause of Lumen Enlargement Immediately After Balloon Pulmonary Angioplasty: Intravascular Ultrasound Analysis in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Circ Cardiovasc Interv. 2018;11:e006010.
    Abstract    

    Abstract available

  44. TAMPAKAKIS E, Shah SJ, Borlaug BA, Leary PJ, et al
    Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease.
    Circ Heart Fail. 2018;11:e004436.
    Abstract    

    Abstract available

  45. PATEL H, Bhutani S, Posimreddy S, Shah P, et al
    The obestiy paradox: the protective effect of obesity on right ventricular function using echocardiographic strain imaging in patients with pulmonary hypertension.
    Minerva Cardioangiol. 2018 Apr 11. pii: S0026-4725.18.04592.
    Abstract    

    Abstract available

  46. BARTENSTEIN P, Saxer S, Appenzeller P, Lichtblau M, et al
    Risk Factor Profiles Achieved with Medical Therapy in Prevalent Patients with Pulmonary Arterial and Distal Chronic Thromboembolic Pulmonary Hypertension.
    Respiration. 2018 Apr 11. pii: 000488000. doi: 10.1159/000488000.
    Abstract    

    Abstract available

  47. WANAMAKER B, Cascino T, McLaughlin V, Oral H, et al
    Atrial Arrhythmias in Pulmonary Hypertension: Pathogenesis, Prognosis and Management.
    Arrhythm Electrophysiol Rev. 2018;7:43-48.
    Abstract    

    Abstract available

  48. NYDEGGER C, Martinelli C, Di Marco F, Bulfamante G, et al
    Phosphodiesterase-5 Inhibition Alleviates Pulmonary Hypertension and Basal Lamina Thickening in Rats Challenged by Chronic Hypoxia.
    Front Physiol. 2018;9:289.
    Abstract    

    Abstract available

  49. RATHINASABAPATHY A, Horowitz A, Horton K, Kumar A, et al
    The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury.
    Front Physiol. 2018;9:180.
    Abstract    

    Abstract available

  50. NILSSON KF, Gozdzik W, Frostell C, Zielinski S, et al
    Organic mononitrites of 1,2-propanediol act as an effective NO-releasing vasodilator in pulmonary hypertension and exhibit no cross-tolerance with nitroglycerin in anesthetized pigs.
    Drug Des Devel Ther. 2018;12:685-694.
    Abstract    

    Abstract available

  51. IRONFIELD CM, Cowie BS
    Focused Cardiac Ultrasound Determines Cause of Cardiovascular Collapse During Thoracic Surgery in a Patient With Undiagnosed Pulmonary Hypertension: A Case Report.
    A A Pract. 2018 Mar 8. doi: 10.1213/XAA.0000000000000760.
    Abstract    

    Abstract available

  52. FLORENTIN J, Coppin E, Vasamsetti SB, Zhao J, et al
    Inflammatory Macrophage Expansion in Pulmonary Hypertension Depends upon Mobilization of Blood-Borne Monocytes.
    J Immunol. 2018 Apr 9. pii: jimmunol.1701287. doi: 10.4049/jimmunol.1701287.
    Abstract    

    Abstract available

  53. CIRULIS MM, Ryan JJ
    Who's Who of Pulmonary Hypertension: Redefining Classification to Advance Precision Care.
    Circ Genom Precis Med. 2018;11:e002116.
    Abstract    



  54. TOUSOULIS D
    Chronic Thromboembolic Pulmonary Hypertension. What we are missing?
    Hellenic J Cardiol. 2018 Apr 6. pii: S1109-9666(18)30135.
    Abstract    



  55. KINSELLA JP, Steinhorn RH, Mullen MP, Hopper RK, et al
    The Left Ventricle in Congenital Diaphragmatic Hernia: Implications for the Management of Pulmonary Hypertension.
    J Pediatr. 2018 Apr 5. pii: S0022-3476(18)30287.
    Abstract    



  56. DU H, Zhao J, Su Z, Liu Y, et al
    Sequencing the exons of human glucocorticoid receptor (NR3C1) gene in Han Chinese with high-altitude pulmonary edema.
    J Physiol Anthropol. 2018;37:7.
    Abstract    

    Abstract available

  57. NIE X, Dai Y, Tan J, Chen Y, et al
    alpha-Solanine reverses pulmonary vascular remodeling and vascular angiogenesis in experimental pulmonary artery hypertension.
    J Hypertens. 2017 Jul 12. doi: 10.1097/HJH.0000000000001475.
    Abstract    

    Abstract available

  58. STORY M, Kwon SK, Robinson R, Fortis S, et al
    Acute cor pulmonale due to pulmonary tumour thrombotic microangiopathy from renal cell carcinoma.
    BMJ Case Rep. 2017;2017.
    Abstract    

    Abstract available

  59. WU X, Xu W, Wang J, Tian X, et al
    Clinical characteristics in lymphangioleiomyomatosis-related pulmonary hypertension: an observation on 50 patients.
    Front Med. 2018 Apr 19. pii: 10.1007/s11684-018-0634.
    Abstract    

    Abstract available

  60. GOMES A, Cruz C, Rocha J, Ricardo M, et al
    Pulmonary hypertension: Real-world data from a Portuguese expert referral centre.
    Pulmonology. 2018 Apr 16. pii: S2531-0437(18)30037.
    Abstract    

    Abstract available

  61. DE-MIGUEL-DIEZ J, Lopez-de-Andres A, Hernandez-Barrera V, Jimenez-Trujillo I, et al
    National trends and outcomes of hospitalizations for pulmonary hypertension in Spain (2001-2014).
    Int J Cardiol. 2018 Apr 7. pii: S0167-5273(17)36555.
    Abstract    

    Abstract available

  62. MEGHWANI H, Prabhakar P, Mohammed SA, Dua P, et al
    Beneficial Effect of Ocimum sanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension in Rats.
    Medicines (Basel). 2018;5.
    Abstract    

    Abstract available

  63. ABUHALIMEH BJ, Desai MY, Tonelli A
    EXPRESS: Diagnosing Pulmonary Hypertension in the Presence of Abnormal Right Heart Structures.
    Pulm Circ. 2018 Jan 1:2045894018773053. doi: 10.1177/2045894018773053.
    Abstract    



  64. CHEBIB N, Mornex JF, Traclet J, Philit F, et al
    EXPRESS: Pulmonary hypertension in chronic lung diseases: comparison to other pulmonary hypertension groups.
    Pulm Circ. 2018 Jan 1:2045894018775056. doi: 10.1177/2045894018775056.
    Abstract    



  65. OGAWA A, Matsubara H
    After the Dawn- Balloon Pulmonary Angioplasty for Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Circ J. 2018 Apr 17. doi: 10.1253/circj.CJ-18-0258.
    Abstract    

    Abstract available

  66. SCELSI CL, Bates WB, Melenevsky YV, Sharma GK, et al
    Egg-and-Banana Sign: A Novel Diagnostic CT Marker for Pulmonary Hypertension.
    AJR Am J Roentgenol. 2018 Apr 18:1-5. doi: 10.2214/AJR.17.19208.
    Abstract    

    Abstract available

  67. SUN XZ, Li SY, Tian XY, Hong Z, et al
    Effect of Rho kinase inhibitor fasudil on the expression ET-1 and NO in rats with hypoxic pulmonary hypertension.
    Clin Hemorheol Microcirc. 2018 Apr 12. pii: CH160232. doi: 10.3233/CH-160232.
    Abstract    

    Abstract available

  68. KAMENSKAYA O, Loginova I, Chernyavskiy A, Edemskiy A, et al
    CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: PREVALENCE AND IMPLICATIONS FOR SURGICAL TREATMENT OUTCOME.
    Clin Respir J. 2018 Apr 16. doi: 10.1111/crj.12898.
    Abstract    

    Abstract available

  69. D'ALTO M, Bossone E, Opotowsky AR, Ghio S, et al
    Strengths and weaknesses of echocardiography for the diagnosis of pulmonary hypertension.
    Int J Cardiol. 2018 Apr 7. pii: S0167-5273(17)33890.
    Abstract    

    Abstract available

  70. FAN Q, An Q
    Letter to editor: Mortality in pulmonary arterial hypertension due to congenital heart disease: Serial changes improve prognostication.
    Int J Cardiol. 2018;254:302.
    Abstract    



  71. WOLFE JD, Hickey GW, Althouse AD, Sharbaugh MS, et al
    Pulmonary Vascular Resistance Determines Mortality in End-Stage Renal Disease Patients with Pulmonary Hypertension.
    Clin Transplant. 2018 Apr 26:e13270. doi: 10.1111/ctr.13270.
    Abstract    

    Abstract available

  72. PARMAKSIZ ET, Inal A, Salepci B, Comert S, et al
    Relationship of asymmetric dimethylarginine levels with disease severity and pulmonary hypertension in chronic obstructive pulmonary disease.
    Lung India. 2018;35:199-203.
    Abstract    

    Abstract available

  73. LEGCHENKO E, Chouvarine P, Borchert P, Fernandez-Gonzalez A, et al
    PPARgamma agonist pioglitazone reverses pulmonary hypertension and prevents right heart failure via fatty acid oxidation.
    Sci Transl Med. 2018;10.
    Abstract    

    Abstract available

  74. SHEIKH AQ, Saddouk FZ, Ntokou A, Mazurek R, et al
    Cell Autonomous and Non-cell Autonomous Regulation of SMC Progenitors in Pulmonary Hypertension.
    Cell Rep. 2018;23:1152-1165.
    Abstract    

    Abstract available

  75. DERLIN T, Kelting C, Hueper K, Weiberg D, et al
    Quantitation of Perfused Lung Volume Using Hybrid SPECT/CT Allows Refining the Assessment of Lung Perfusion and Estimating Disease Extent in Chronic Thromboembolic Pulmonary Hypertension.
    Clin Nucl Med. 2018 Apr 23. doi: 10.1097/RLU.0000000000002085.
    Abstract    

    Abstract available

  76. ALFRAIDI H, Qanash S, Bshouty Z
    Pulmonary Arterial Hypertension Specific Therapy in Patients with Combined Post- and Precapillary Pulmonary Hypertension.
    Pulm Med. 2018;2018:7056360.
    Abstract    

    Abstract available

  77. ZAKLICZYNSKI M, Pacholewicz J, Copik I, Maruszewski M, et al
    Mechanical circulatory support is effective to treat pulmonary hypertension in heart transplant candidates disqualified due to unacceptable pulmonary vascular resistance.
    Kardiochir Torakochirurgia Pol. 2018;15:23-26.
    Abstract    

    Abstract available

  78. MORITA T, Nakamura K, Tatsuyuki O, Kobayashi A, et al
    Pulmonary hypertension due to unclassified interstitial lung disease in a Pembroke Welsh corgi.
    J Vet Med Sci. 2018 Apr 23. doi: 10.1292/jvms.17-0716.
    Abstract    

    Abstract available

  79. KIBE M, Ibara S, Inagaki H, Kato T, et al
    Lethal persistent pulmonary hypertension of the newborn in Bohring-Opitz syndrome.
    Am J Med Genet A. 2018;176:1245-1248.
    Abstract    

    Abstract available

  80. ALUSHI B, Beckhoff F, Leistner D, Franz M, et al
    Pulmonary Hypertension in Patients With Severe Aortic Stenosis: Prognostic Impact After Transcatheter Aortic Valve Replacement: Pulmonary Hypertension in Patients Undergoing TAVR.
    JACC Cardiovasc Imaging. 2018 Apr 13. pii: S1936-878X(18)30212.
    Abstract    

    Abstract available

  81. ODA K, Yatera K, Fujino Y, Kido T, et al
    Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
    Respir Investig. 2018;56:64-71.
    Abstract    

    Abstract available

  82. SCHWARTZ SS, Madsen N, Laursen HB, Hirsch R, et al
    Incidence and Mortality of Adults With Pulmonary Hypertension and Congenital Heart Disease.
    Am J Cardiol. 2018 Mar 14. pii: S0002-9149(18)30287.
    Abstract    

    Abstract available

  83. ZHONG Y, Catheline D, Houeijeh A, Sharma D, et al
    Maternal PUFA omega-3 supplementation prevents hyperoxia-induced pulmonary hypertension in the offspring.
    Am J Physiol Lung Cell Mol Physiol. 2018 Mar 29. doi: 10.1152/ajplung.00527.2017
    Abstract    

    Abstract available

  84. WEST JD, Carrier EJ
    Precision Modeling of Pulmonary Hypertension Pathology with iPSC-derived Cells.
    Am J Respir Crit Care Med. 2018 Mar 29. doi: 10.1164/rccm.201803-0480.
    Abstract    



  85. BARNES JW, Patel RP
    Things We 'kNOw' and Don't 'kNOw' About Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Mar 28. doi: 10.1164/rccm.201803-0424.
    Abstract    



  86. ZHANG J, Dong J, Martin M, He M, et al
    AMPK Phosphorylation of ACE2 in Endothelium Mitigates Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Mar 23. doi: 10.1164/rccm.201712-2570.
    Abstract    

    Abstract available

  87. AGARWAL MA, Shah M, Patel B, Nolan VG, et al
    Association between Pulmonary Hypertension and Clinical Outcomes in Hospitalized Sickle Cell Disease Patients.
    Am J Respir Crit Care Med. 2018 Apr 12. doi: 10.1164/rccm.201802-0261.
    Abstract    



  88. HU Y, Zabini D, Gu W, Goldenberg NM, et al
    The Role of the Human Immune System in Chronic Hypoxic Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Apr 9. doi: 10.1164/rccm.201711-2175.
    Abstract    



  89. DAI Z, Zhu MM, Peng Y, Jin H, et al
    Endothelial and Smooth Muscle Cell Interaction via FoxM1 Signaling Mediates Vascular Remodeling and Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2018 Apr 17. doi: 10.1164/rccm.201709-1835.
    Abstract    

    Abstract available

  90. STENMARK KR, Hu CJ, Pullamsetti SS
    How Many Foxs Are There on the Road to Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2018 Apr 25. doi: 10.1164/rccm.201804-0702.
    Abstract    



  91. MATHAI SC, Mathew S
    Breathing (and Coding?) a Bit Easier: Changes to International Classification of Disease Coding for Pulmonary Hypertension.
    Chest. 2018 Apr 20. pii: S0012-3692(18)30568-3. doi: 10.1016/j.chest.2018.
    Abstract    

    Abstract available

  92. LEOPOLD JA
    Pulmonary Venous Remodeling in Pulmonary Hypertension: The Veins Take Center Stage.
    Circulation. 2018;137:1811-1813.
    Abstract    



  93. GERGES C, Gerges M, Fesler P, Maria Pistritto A, et al
    In-depth hemodynamic phenotyping of pulmonary hypertension due to left heart disease.
    Eur Respir J. 2018 Mar 29. pii: 13993003.00067-2018.
    Abstract    

    Abstract available

  94. HOEPER MM
    Chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: to screen or not to screen?
    Eur Respir J. 2018;51.
    Abstract    



  95. JENKINS D
    New interventions to treat chronic thromboembolic pulmonary hypertension.
    Heart. 2018 Apr 10. pii: heartjnl-2017-312110. doi: 10.1136/heartjnl-2017-312110
    Abstract    

    Abstract available

  96. SHAH PR, Boisen ML, Winger DG, Marquez J, et al
    Corrigendum to 'Extracorporeal Support During Bilateral Sequential Lung Transplantation in Patients with Pulmonary Hypertension: Risk factors and Outcomes' [Journal of Cardiothoracic and Vascular Anesthesia volume 31/2 (2017) 418-425].
    J Cardiothorac Vasc Anesth. 2018 Mar 19. pii: S1053-0770(18)30111.
    Abstract    



  97. BENZA RL, Farber HW, Frost A, Grunig E, et al
    REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat.
    J Heart Lung Transplant. 2018 Mar 1. pii: S1053-2498(18)31381.
    Abstract    

    Abstract available

  98. GOPALAKRISHNAN A, Kumar Mohanan Nair K, Harikrishnan S, Valaparambil A, et al
    An Unusual Case of Persistent Severe Pulmonary Artery Hypertension Following Balloon Mitral Valvuloplasty.
    J Heart Valve Dis. 2016;25:195-197.
    Abstract    

    Abstract available

  99. PISANO C, Rita Balistreri C, Fabio Triolo O, Franchino R, et al
    Impact of Prosthesis-Patient Mismatch after Mitral Valve Replacement.
    J Heart Valve Dis. 2016;25:39-45.
    Abstract    

    Abstract available

  100. ALENCAR AK, Carvalho FI, Silva AM, Martinez ST, et al
    Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A2A receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats.
    PLoS One. 2018;13:e0195047.
    Abstract    

    Abstract available

  101. BAKEER N, James J, Roy S, Wansapura J, et al
    Sickle cell anemia mice develop a unique cardiomyopathy with restrictive physiology.
    Proc Natl Acad Sci U S A. 2016 Aug 8. pii: 201600311.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;